This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Dermatologic Disorders, Other  • Alert me on articles by topic

A Responsive Instrument to Measure Activity and Damage in Patients With Cutaneous Lupus Erythematosus

Zuleika L. Bonilla-Martinez, MD; Joerg Albrecht, MD; Andrea B. Troxel, ScD; Lynne Taylor, PhD; Joyce Okawa, RN; Sam Dulay, BA; Victoria P. Werth, MD

Arch Dermatol. 2008;144(2):173-180.

Objective  To assess the clinical responsiveness of the CLASI (Cutaneous Lupus Erythematosus [CLE] Disease Area and Severity Index).

Design  Validation cohort.

Setting  Tertiary referral center.

Patients  Eight patients with CLE.

Intervention  Assessment of patients with CLE from baseline until day 56 after starting a new standard of care therapy.

Main Outcome Measures  Correlation of the baseline to day-56 change in 2 CLASI scales (disease activity and damage), with baseline to day-56 change in the physicians' and patients' assessments of patient's global skin health scores, and the patients' assessments of pain and itch.

Results  The change in CLASI activity score highly correlated with the changes in 3 clinical validation measures: physicians' assessment of skin health (r = 0.97; P = .003; n = 7), patients' global skin health score (r = 0.85; P = .007; n = 8), and pain (r = 0.98; P = .004; n = 5). Using the Wilcoxon signed-rank test, paired baseline to day-56 changes in CLASI activity and damage scores were analyzed for the 2 subgroups (meaningful change vs nonmeaningful change) composing each validation variable. Change in CLASI activity was significantly different for patients who had a meaningful change in their global skin self-ratings (Z = 1.07; P = .03) and approached statistical significance for patients who had a meaningful change in their level of itching (Z = 1.83; P = .06) and their physicians' global skin rating (Z = 1.84; P = .06). The CLASI activity score decreases after successful therapeutic intervention, whereas the damage score may increase in scarring forms of CLE.

Conclusion  The activity score of the CLASI correlates with the improvement of global skin health, pain, and itch and is thus a useful tool to measure clinical response.

Author Affiliations: Departments of Dermatology (Drs Bonilla-Martinez, Albrecht, and Werth, Ms Okawa, and Mr Dulay) and Biostatistics and Epidemiology (Drs Troxel and Taylor), University of Pennsylvania, Philadelphia; and Philadelphia Veterans Affairs Hospital (Dr Werth).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Quality of Life and Disease Severity in a Cutaneous Lupus Erythematosus Pilot Study
Gaines et al.
Arch Dermatol 2008;144:1061-1062.
FULL TEXT